Decentralized Clinical Trials: Overcoming Challenges and Embracing Opportunities in Supporting Investigators and Patients

Decentralized clinical trials are reshaping how studies are designed, conducted and experienced — by sponsors, sites, investigators and patients alike. But what does this shift mean for the CRA? In this session, Cristina Florescu draws on over two decades of clinical research experience to explore the practical realities of DCTs: the opportunities they create for more flexible, patient-centred monitoring, and the challenges they introduce for oversight, communication and quality assurance. Attendees will leave with a clearer understanding of how to navigate the evolving landscape of decentralised research and strengthen their role as the connective thread between sponsors, sites and patients.